LXR Agonist Inhibits Inflammation Through Regulating MyD88 Mrna Alternative Splicing
Frontiers in Pharmacology（2022）
Key words
LXR,inflammation,MyD88,alternative splicing,multi-target,TLR4
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined